Loading...
Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension
BACKGROUND: Despite the increased risk for pulmonary hypertension in children with Down syndrome, the response to treatment with targeted therapies for pulmonary hypertension in these patients is not well characterized. The Sildenafil in Treatment-naive children, Aged 1–17 years, with pulmonary arte...
Saved in:
| Published in: | BMC Cardiovasc Disord |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5496590/ https://ncbi.nlm.nih.gov/pubmed/28676038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-017-0569-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|